[
    [
        {
            "time": "2021-10-25",
            "original_text": "关注低估值、低位置血制品、消费医疗板块，重点推荐博雅生物、鱼跃医疗等!【东吴医药朱国广团队】",
            "features": {
                "keywords": [
                    "低估值",
                    "血制品",
                    "消费医疗",
                    "博雅生物",
                    "鱼跃医疗"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "关注低估值、低位置血制品、消费医疗板块，重点推荐博雅生物、鱼跃医疗等!【东吴医药朱国广团队】",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-10-25",
            "original_text": "生物医药行业周报：三季报即将集中披露 建议关注业绩确定性较强的公司",
            "features": {
                "keywords": [
                    "生物医药",
                    "三季报",
                    "业绩确定性"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "生物医药行业周报：三季报即将集中披露 建议关注业绩确定性较强的公司",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-25",
            "original_text": "快讯 | 凯莱英全资收购临床数据管理和统计服务公司医普科诺",
            "features": {
                "keywords": [
                    "凯莱英",
                    "全资收购",
                    "医普科诺",
                    "临床数据管理"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "快讯 | 凯莱英全资收购临床数据管理和统计服务公司医普科诺",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-25",
            "original_text": "凯莱英：公司致力于为国内外制药公司、生物技术公司提供药品全生命周期的一站式CMC服务、高效和高质量的研发与生产服务",
            "features": {
                "keywords": [
                    "凯莱英",
                    "CMC服务",
                    "研发与生产服务"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "凯莱英：公司致力于为国内外制药公司、生物技术公司提供药品全生命周期的一站式CMC服务、高效和高质量的研发与生产服务",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-10-25",
            "original_text": "诺泰生物上市半年股价腰斩 研发人员半年仅增3人",
            "features": {
                "keywords": [
                    "诺泰生物",
                    "股价腰斩",
                    "研发人员"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "诺泰生物上市半年股价腰斩 研发人员半年仅增3人",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-25",
            "original_text": "信达证券发布凯莱英研报，公司点评报告：收购医普科诺，完善临床CRO业务，提升一体化能力",
            "features": {
                "keywords": [
                    "信达证券",
                    "凯莱英",
                    "医普科诺",
                    "临床CRO业务"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "信达证券发布凯莱英研报，公司点评报告：收购医普科诺，完善临床CRO业务，提升一体化能力",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-25",
            "original_text": "信达证券：给予凯莱英评级",
            "features": {
                "keywords": [
                    "信达证券",
                    "凯莱英",
                    "评级"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "信达证券：给予凯莱英评级",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-10-25",
            "original_text": "临床CRO服务提质提速，凯莱英旗下凯诺医药全资收购医普科诺",
            "features": {
                "keywords": [
                    "临床CRO服务",
                    "凯莱英",
                    "凯诺医药",
                    "医普科诺"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "临床CRO服务提质提速，凯莱英旗下凯诺医药全资收购医普科诺",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-10-25",
            "original_text": "21健讯Daily｜华润双鹤与美企合作开发新冠口服药；金斯瑞与艾博、沃森达成mRNA疫苗合作",
            "features": {
                "keywords": [
                    "华润双鹤",
                    "新冠口服药",
                    "金斯瑞",
                    "mRNA疫苗",
                    "合作"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "21健讯Daily｜华润双鹤与美企合作开发新冠口服药；金斯瑞与艾博、沃森达成mRNA疫苗合作",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-25",
            "original_text": "凯莱英发布公告 全资子公司与医普科诺签股权转让协议",
            "features": {
                "keywords": [
                    "凯莱英",
                    "全资子公司",
                    "医普科诺",
                    "股权转让协议"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "凯莱英发布公告 全资子公司与医普科诺签股权转让协议",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-25",
            "original_text": "A股早报2021年10月25日星期一",
            "features": {
                "keywords": [
                    "A股早报"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "A股早报2021年10月25日星期一",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-10-25",
            "original_text": "盘前有料丨国家发改委：派出调查组开展煤炭价格成本专项调查…重要消息还有这些",
            "features": {
                "keywords": [
                    "国家发改委",
                    "煤炭价格",
                    "专项调查"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "能源"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "盘前有料丨国家发改委：派出调查组开展煤炭价格成本专项调查…重要消息还有这些",
                "Correlation": 1,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]